(Q36686865)

15 August 2017

1 reference

title

Pathogenesis of bacterial exacerbations of COPD. (English)

1 reference

15 August 2017

author name string

Sateesh B Veeramachaneni

series ordinal

1

1 reference

15 August 2017

Sanjay Sethi

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

109-115

1 reference

The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Role of infection in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Bacterial infection in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Do bacteria cause exacerbations of COPD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

The role of bacteria in exacerbations of COPD. A constructive view

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Molecular epidemiology: application of contemporary techniques to the typing of microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Nontypeable Haemophilus influenzae in carriage and disease: a difference in IgA1 protease activity levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Innate immunity in the lung: how epithelial cells fight against respiratory pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

How do viral infections predispose patients to bacterial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600651347

10.1080/15412550600651347

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference